Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Diagnostic Predictive Value of Platelet Indices Evaluated

By LabMedica International staff writers
Posted on 31 Aug 2016
The two main causes of thrombocytopenia excluding pseudo thrombocytopenia are increase destruction or peripheral consumption also known as hyper-destructive thrombocytopenia. More...
Decreased platelet productions or hypo-production thrombocytopenia are associated with a number of bone marrow diseases.

The gold standard method for discriminating the causes of immune thrombocytopenic purpura (ITP), disseminated intravascular coagulation (DIC), and thrombotic thrombocytopenic purpura (TTP) is bone marrow examination. Due to its invasiveness and being unfriendly for the patients, this procedure is not recommended as first line diagnosis. ITP still remains a diagnosis by exclusion due to lack of accurate clinical and laboratory parameters.

Hematologists at the College of Health Sciences (Addis Ababa University, Ethiopia) conducted a prospective cross-sectional study on 83 thrombocytopenic patients whose platelet count was less than 150 × 109/L. From these, 50 patients had hypoproductive and the rest 33 had Immune Thrombocytopenia Purpura (ITP). Age and sex matched 42 healthy controls were included as a comparative group. Bone marrow examination was performed in all 50 hypoproductive patients and in 10 of the 33 ITP patients as part of their medical follow up and diagnosis. Females were the predominant study participants in ITP patients, while males were predominant in the hypo productive group.

Blood sample for complete blood count (CBC) analysis was collected into 5 mL EDTA anti-coagulated tube and CBC analysis was performed using the XT 2000i fully automated hematology analyzer (Sysmex Corporation, Kobe, Japan). This analyzer measures white blood cells (WBC) and reticulocytes with an optical detector block based on the flow cytometry principle, red blood cells (RBC) and platelet counts are analyzed via the impedance method. The performance of the instrument was monitored by running quality control materials. A peripheral blood smear was also reviewed to estimate platelet counts, rule out pseudo thrombocytopenia and fragments of cells like shistocytes.

All platelet indices were significantly higher in ITP patients than in hypoproductive thrombocytopenic patients. In particular mean platelet volume (MPV) and Platelet Large Cell-Ratio (P-LCR) have larger area under ROC curve, 0.876 and 0.816, respectively, indicating a better predictive capacity, sensitivity and specificity in discriminating the two causes of thrombocytopenia. The indices were still significantly higher in ITP patients compared to 42 healthy controls. A significant negative correlation was observed between platelet count and platelet indices in ITP patients.

The authors concluded that Platelet Distribution Width (PDW), MPV, and P-LCR help in predicting thrombocytopenic patients as having ITP or hypoproductive thrombocytopenia. If these indices are used in line with other laboratory and clinical information, they may help in delaying/ avoiding unnecessary bone marrow aspiration in ITP patients or supplement a request for bone morrow aspiration or biopsy in hypoproductive thrombocytopenic patients. The study was published on July 1, 2016, in the journal BMC Hematology.

Related Links:
Addis Ababa University
Sysmex

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.